AliveCor, Inc., headquartered in San Francisco, and maker of the first FDA-approved smartphone device, has teamed up with Apollo Hospitals in India to provide heart monitoring capabilities for people affected by arrhythmia. The collaboration is part of an effort to improve the ability to detect atrial fibrillation and prevent strokes, the two companies said in a press release.
AliveCor’s heart monitor–AliveECG–is compatible with iOS and Android mobile devices and can record, display, store and transfer heart rate and single-channel electrocardiograms reports FierceMedicalDevices.
The device fits snugly on to the back of a smartphone. It records heart rhythm when a person places two fingers on electrodes to take a 30-second reading. Results are then delivered to an app, which alerts the patient if they have a normal or abnormal heart rhythm, and these results can be emailed or printed out to a physician.
“It’s extremely important for us to provide access to medical devices that are both clinically proven and cost-effective to help our patients manage their cardiac health,” Prathap C. Reddy, chairman of Apollo Hospitals, said in a statement.
